GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Akso Health Group (FRA:8HX) » Definitions » Research & Development

Akso Health Group (FRA:8HX) Research & Development : €0.00 Mil (TTM As of Sep. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Akso Health Group Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Akso Health Group's Research & Development for the six months ended in Sep. 2023 was €0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2023 was €0.00 Mil.

Akso Health Group Research & Development Historical Data

The historical data trend for Akso Health Group's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akso Health Group Research & Development Chart

Akso Health Group Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Research & Development
Get a 7-Day Free Trial Premium Member Only - 0.94 0.46 0.38 -

Akso Health Group Semi-Annual Data
Mar15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Akso Health Group Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Akso Health Group  (FRA:8HX) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Akso Health Group Research & Development Related Terms

Thank you for viewing the detailed overview of Akso Health Group's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Akso Health Group (FRA:8HX) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Akso Health Group (FRA:8HX) » Definitions » Research & Development
Comparable Companies
COSM ENMI ACBM MCK COR CAH HSIC SHSE:601607 HKSE:01099 MIL:AMP NZSE:EBO XSWX:GALE TSE:7459 TSE:2784 PDCO SHSE:600739 TSE:9987 SHSE:600056 SZSE:000028 XKRX:008930
Traded in Other Exchanges
AHG:USA
Address
No. 44, Moscow Road, Qianwan Bonded Port Area, Room 8201-4-4(A), 2nd Floor, Qiantongyuan Building, Qingdao Pilot Free Trade Zone, Shandong, CHN
Website
http://www.xiaobaimaimai.com
Akso Health Group formerly Xiaobai Maimai Inc is a social e-commerce platform based in China. The company collaborates with domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products on its social e-commerce platform. It operates in two segments namely online marketplace and health devices. It generates the majority of revenue from the health devices segment.

Akso Health Group (FRA:8HX) Headlines

No Headlines